Results 251 to 260 of about 232,441 (272)

Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria.

, 1993
S L Liu, Andrew Hessel, K E Sanderson
openalex   +1 more source

Genomic analysis of bovine respiratory disease resistance in preweaned dairy calves diagnosed by a combination of clinical signs and thoracic ultrasonography. [PDF]

PLoS One
Strillacci MG, Ferrulli V, Bernini F, Pravettoni D, Bagnato A, Martucci I, Boccardo A.   +6 more
europepmc   +1 more source

Inverse splicing of a group II intron.

, 1993
Kevin A. Jarrell
openalex   +1 more source

An Actively Homing Insertion Element in a Phage Methylase Contains a Hidden HNH Endonuclease. [PDF]

Genes (Basel)
Arsenault D, Gosselin SP, Gogarten JP.
europepmc   +1 more source

Baseline Sensitivity of Botryosphaeria spp. Isolated from Apples to Pyraclostrobin in Korea. [PDF]

Plant Pathol J
Lim GJ, Kim HD, Choi JW, Nam YJ, Lee HK, Lee SY, Jung HY.   +6 more
europepmc   +1 more source

Insights Into Genetic Variations of the OCT1 Gene in Metformin Poor Responders Among Bangladeshi Type 2 Diabetic Patients. [PDF]

Adv Pharmacol Pharm Sci
Begum R, Das A, Alam MJ, Sultana GNN.
europepmc   +1 more source

Mechanisms of enhancer‐driven oncogene activation

International Journal of Cancer, EarlyView.
Abstract An aggressive subtype of acute myeloid leukemia (AML) is caused by enhancer hijacking resulting in MECOM overexpression. Several chromosomal rearrangements can lead to this: the most common (inv(3)/t(3;3)) results in a hijacked GATA2 enhancer, and there are several atypical MECOM rearrangements involving enhancers from other hematopoietic ...
Joyce Vriend, Ruud Delwel, Dorien Pastoors   +2 more
wiley   +1 more source

Alu-Sc-mediated exonization generated a mitochondrial LKB1 gene variant found only in higher order primates. [PDF]

Sci Rep
Tan I, Chothani S, Lim HH, Lam KP.
europepmc   +1 more source

TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study

International Journal of Cancer, EarlyView.
What's New? Tumor necrosis factor (TNF) can promote tumor resistance to immune checkpoint inhibitors (ICIs), which are now the standard treatment for advanced melanoma patients. Here, in an advanced melanoma patient cohort, TNF was investigated for a possible predictive relationship with ICI response. Assessments show that after 12 weeks of ICI therapy,
Mathieu Virazels, Amélie Lusque, Stéphanie Brayer, Matthieu Genais, Carine Dufau, Jean Milhès, Thomas Filleron, Cécile Pagès, Vincent Sibaud, Laurent Mortier, Olivier Dereure, Maha Ayyoub, Amandine Fabre, Nathalie Andrieu‐Abadie, Vera Pancaldi, Céline Colacios, Nicolas Meyer, Bruno Ségui, Anne Montfort   +18 more
wiley   +1 more source

A Novel 6-bp Repeat Unit (6-bp RU) of the 13th Intron Within the Conserved <i>EPAS1</i> Gene in Plateau Pika Is Capable of Altering Enhancer Activity. [PDF]

Int J Mol Sci
Tang Q, Xu Y, Song Q, Cao S, Li Y, Lan X, Zhang L, Pan C.   +7 more
europepmc   +1 more source